Essence Magazine:
Getty By Dominique Fluker ·Updated September 16, 2023
Recently, Moderna, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Spikevax® for ages 12 years and above. Emergency Use Authorization (EUA) for the Moderna COVID-19 vaccine was also received for individuals six months through 11 years of age. Moderna’s updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of
This post first appeared in Essence Magazine. Read the original article.